Medford Pharmaceuticals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 M
About Medford Pharmaceuticals Llp
Medford Pharmaceuticals Llp (MPL) is 6 Year, 1 Month old Limited Liability Partnership 19 December 2018. Its registered office is in Bangalore, Karnataka, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
-
Location
Bangalore, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAN-8052
-
Incorporation Date
19 Dec 2018
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Bangalore
-
Company Classification
Limited Liability Partnership
Industry
What products or services does Medford Pharmaceuticals Llp offer?
Medford Pharmaceuticals Llp offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Pain Relief Drugs & Pharmaceuticals, Pain Killers.
Who are the key members and board of directors at Medford Pharmaceuticals Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kongarahalli Nagaraja
|
Designated Partner | 19-Dec-2018 | Current |
|
Geethanjali Chandrareddy
|
Designated Partner | 19-Dec-2018 | Current |
Financial Performance of Medford Pharmaceuticals Llp.
Enhance accessibility to Medford Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medford Pharmaceuticals Llp?
Unlock access to Medford Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
G S S Pharma Private LimitedGeethanjali Chandrareddy and Kongarahalli Nagaraja are mutual person
Charges (Loans)
₹7.50 M
₹0
Charges Breakdown by Lending Institutions
- Idfc First Bank Limited : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jun 2023 | Idfc First Bank Limited | ₹7.50 M | Open |
How Many Employees Work at Medford Pharmaceuticals Llp?
Medford Pharmaceuticals Llp has a workforce of 36 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medford Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medford Pharmaceuticals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.